Small Molecule Drug Discovery Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2027


Karanshendage1089

Uploaded on Feb 23, 2023

Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. Read More:- https://www.theinsightpartners.com/reports/small-molecule-drug-discovery-market

Comments

                     

Small Molecule Drug Discovery Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2027

Small Molecule Drug Discovery Market Global Analysis and Forecast to 2027 Published Date : May 2020 Email: [email protected] Email: [email protected] Report Studies  Small Molecule Drug Discovery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas); Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development); and Geography 2 Email: [email protected] $50,000 Small Molecule Drug $40,000 Discovery Market Value $30,000 CAGR of 9.5% $20,000 (2020 to 2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX 3 Email: [email protected] Small Molecule Drug Discovery Market Overview  The small molecule drug discovery market was valued at US$ 24,976.14 million in 2019 and is projected to reach US$ 50,823.06 Mn by 2027; it is expected to grow at a CAGR of 9.5% from 2020 to 2027.  The small molecule drug discovery market is expected to grow owing to factors such as increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments. However, high drug development cost is likely to restrain the growth of the market during the forecast period. 4 Email: [email protected] Key Segment Market Segment By Type:-  Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas)  Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development) 5 Email: [email protected] Company Profiles  Johnson and Johnson Services, Inc.  Teva Pharmaceutical Industries Ltd  Boehringer Ingelheim International GmbH  Allergan Plc.  Pfizer Inc.  Bristol-Myers Squibb Company  MERCK KGaA  GlaxoSmithKline plc.  AstraZeneca  Gilead Sciences, Inc. 6 Download Sample Her e Email: [email protected] By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7 THANK YOU! Phone : +1-646-491-9876 E-Mail : [email protected]